Cost-effectiveness analysis of policy options on first-line treatments for advanced, non-small cell lung cancer in Thailand-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-effectiveness analysis of policy options on first-line treatments for advanced, non-small cell lung cancer in Thailand

Published:2018-06 Issue: Volume:120 Page:91-97
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Limwattananon Chulaporn,Limwattananon Supon,Waleekhachonloet Onanong,Rattanachotphanit Thananan

Funder

Health Intervention and Technology Assessment Program (HITAP)

Food and Drug Administration, Ministry of Public Health, Thailand

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference43 articles.

1. Cancer in Thailand. Vol VIII (2010–2012),2015

2. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;D’Addario;Ann. Oncol.,2010

3. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Crinò;Ann. Oncol.,2010

4. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

5. Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence;Mitsudomi;J. Clin. Oncol.,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of health state utility values in Thai cancer patients;Expert Review of Pharmacoeconomics & Outcomes Research;2022-09-26

2. Cost‐effectiveness of precision diagnostic testing for precision medicine approaches against non‐small‐cell lung cancer: A systematic review;Molecular Oncology;2021-07-19

3. Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung Cancer;PharmacoEconomics;2020-08-05

4.

A Systematic Review of Health Economic Evaluation on Targeted Therapies for First-Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Quality Evaluation

;Cancer Management and Research;2020-06

5. Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan;PLOS ONE;2020-04-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3